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Abstract
Background: The yeast cell cycle is largely controlled by the cyclin-dependent kinase (CDK)
Cdc28. Recent evidence suggests that both CDK complex stability as well as function during mitosis
is determined by precise regulation of Swe1, a CDK inhibitory kinase and cyclin binding partner. A
model of mitotic progression has been provided by study of filamentous yeast. When facing
nutrient-limited conditions, Ras2-mediated PKA and MAPK signaling cascades induce a switch from
round to filamentous morphology resulting in delayed mitotic progression.
Results: To delineate how the dimorphic switch contributes to cell cycle regulation, temperature
sensitive cdc28 mutants exhibiting constitutive filamentation were subjected to epistasis analyses
with RAS2 signaling effectors. It was found that Swe1-mediated inhibitory tyrosine phosphorylation
of Cdc28 during filamentous growth is in part mediated by Ras2 activation of PKA, but not Kss1-
MAPK, signaling. This pathway is further influenced by Cks1, a conserved CDK-binding partner of
elusive function with multiple proposed roles in CDK activation, transcriptional regulation and
ubiquitin-mediated proteasome degradation.
Conclusion: The dynamic balance between Cks1- and Swe1-dependent regulation of Cdc28 and,
thereby, the timing of mitosis during yeast dimorphism is regulated in part by Ras2/cAMP-mediated
PKA signaling, a key pathway controlling filamentous growth.
Background
Yeast cell division is tightly coupled to morphology. Pro-
gression through mitosis activates an apical-isotropic
switch in which polarized bud growth is redirected to pro-
duce round daughter cells [1]. Conversely, mitotic delay
results in filamentous growth allowing spreading away
from the colony center. Thus, filamentation may be elic-
ited by mutations in mitotic regulators such as the cyclin-
dependent kinase (CDK) Cdc28 or its mitotic cyclin bind-
ing partner Clb2 [2-4]. Cdc28/Clb2 complexes phosphor-
ylate hundreds of effectors containing S/TP sites,
preferably (S/T)PX(K/R), including mitotic spindle com-
ponents, signaling proteins and other cell cycle regulators
[5,6].
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The switch from round to filamentous growth is stimu-
lated physiologically by environmental conditions
including low nitrogen availability or fusel alcohol expo-
sure [7]. Although it has been hypothesized that these
stimuli impinge on CDK and/or its regulators, no clear
mechanism has emerged. Extracellular signals are con-
veyed through a member of the highly conserved RAS
GTPase family, Ras2. Deletion of RAS2 diminishes filam-
entation, while the dominant allele RAS2-VAL19 induces
constitutive pseudohyphal differentiation [2]. Ras2 acti-
vates both the Sterile (Ste) Mitogen-Activated Protein
Kinase (MAPK) and the Protein Kinase A (PKA) – cAMP
cascades [8]. The MAPK pathway involves sequential acti-
vation of the PAK kinase Ste20, the MAPKKK Ste11, the
MAPKK Ste7 and the MAPK Kss1, culminating in the acti-
vation of the transcription factors Tec1 and Ste12 [9,10].
Accordingly, overproduction of Tec1 induces filamenta-
tion [11], while deletion of TEC1 decreases filament for-
mation [12]. On the other hand, in the PKA pathway, the
PKA subunit Tpk2 specifically activates filamentation by
activation of the transcription factor Flo8 and inhibition
of the transcriptional repressor Sfl1 [13,14]. Deletion of
FLO8 diminishes filamentation, whereas deletion of SFL1
enhances filamentation [12]. Production of cAMP is
opposed by phosphodiesterases Pde1 and Pde2 which
when overexpressed reverse some RAS2-V19 phenotypes
[15,16].
One possible target of Ras2 signaling may be the Wee
kinase Swe1. Swe1 inhibits Cdc28-Clb2 activity at G2/M
via phosphorylation of Cdc28 Tyr19 and a phosphoryla-
tion-independent mechanism [17]. Overexpression of
Swe1 or stabilization of Swe1 delays mitosis and pro-
motes cell elongation and hyperfilamentation [17-19].
Tyrosine-19 may make direct contact with ATP [20], and
it is thought that phosphorylation and even binding by
Swe1 impedes ATP utilization by Cdc28. In turn, initial
Swe1 phosphorylation by Cdc28/Clb2 complexes stabi-
lizes its interaction with Cdc28, potentiating further inhi-
bition. Inhibition is alleviated by Mih1, a CDK tyrosine
phosphatase, which reactivates Cdc28 to hyperphosphor-
ylate Swe1 leading to its dissociation from CDK com-
plexes [21]. Swe1 is also controlled by the Nim1 kinase
Hsl1. Deletion of HSL1 results in increased Cdc28 tyro-
sine-19 phosphorylation [22] and enhanced filamenta-
tion [17,18], whereas overexpression of HSL1  leads to
diminished Swe1 protein levels [23]. Further, deletion of
HSL1 restores filamentation in the absence of FLO8 and
to a lesser degree TEC1, but not in flo8 tec1 double
mutants [18]. This suggests that PKA has greater specificity
for Swe1 inhibition of Cdc28.
PKA has also been shown to mediate Ras2 and glucose-
dependent inhibition of the anaphase-promoting com-
plex (APC) [24,25]. The APC is a ubiquitin-protein ligase
complex that functions to target proteins for destruction
by the proteasome [26]. Overexpression of both the APC-
activator CDC20 as well as negative regulators of the PKA
pathway PDE2 and BCY1 were found to suppress the tem-
perature sensitivity of a cohesin mutant [27]. Further anal-
ysis showed that inhibition of PKA also suppressed
temperature sensitivity of cdc16-1  mutant defective in
APC function [27]. Together these studies indicate the
possibility that PKA may negatively regulate the APC.
Such a mechanism may further separate the role of PKA
from Kss1-MAPK in the regulation of filamentous growth.
Importantly, Cdc28 is also intimately linked to APC acti-
vation. Cdc20-dependent APC activity during mitosis is
positively regulated via phosphorylation by Cdc28 [28].
Reduced binding of Cdc20 to the APC has been observed
in the presence of cdc28-Y18V, T19F, a mutant resistant to
Swe1 mediated phosphorylation [28]. Further, the CDK
subunit Cks1 is required for transcription of CDC20. The
precise mechanism remains obscure but has been pro-
posed to involve Cks1 recruitment of the proteasome to
Cdc28 complexes [29]. Cks1 has been shown to physi-
cally interact with proteasome subunits [30]. Interest-
ingly, while certain cks1  temperature-sensitive alleles
confer G2/M delay [31], Clb cyclin-Cdc28 complexes do
not require Cks1 for normal kinase activity [31,32].
To further elucidate the pathway by which extracellular
signals impinge on cell cycle, we screened for temperature
sensitive cdc28 mutants that perform enhanced filamen-
tous growth. A preponderance of the mutations localized
to the binding region of Cks1. We examined the genetic
interactions of these mutants with cell cycle regulators
and Ras2 signaling components. Our results indicate that
the PKA-cAMP pathway may be an additional signaling
mechanism by which Swe1 inhibition of Cdc28 is
affected. However, Swe1 function is downregulated by a
mechanism requiring association of Cdc28 with Cks1.
Results
cdc28 mutants suggest Cks1 is a regulator of filamentation
We hypothesized that constitutively filamentous cdc28
mutants, which experience growth arrest at elevated tem-
peratures would be valuable tools to identify connections
between cell cycle and extracellular signals. Therefore, a
cdc28  shuffle strain was created in which homozygous
replacement of CDC28 with TRP1 gene was covered by a
URA3 marked plasmid harboring CDC28. Transformation
of this strain with a library of degenerate-PCR derived
cdc28 alleles on a HIS3 marked plasmid, followed by neg-
ative selection against URA3 allowed screening colonies
for mutants exhibiting enhanced filamentous growth on
low nitrogen media. Five hundred colonies were selected
[3]. Secondary screening of these colonies for those thatCell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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exhibited temperature sensitive growth at 35°C revealed
39 mutants with one to five amino acid substitutions.
Cyclin-dependent kinase is a bi-lobed protein with an
amino terminal domain composed primarily of β-sheets
and a larger carboxy-terminal domain containing several
α-helices. Between these two domains lies the catalytic
core, the opening of which is covered by the T-loop (acti-
vation loop) in the inactive monomeric state [20,33-35].
We have previously modeled Cdc28 based on the crystal
structure of the human CDK2 enzyme [3,36]. Mapping
the residues modified in the selected mutants on our
model revealed that while some fell within the interior of
the molecule, many were surface residues predicted to
participate in binding to known essential partners (Fig. 1).
Several mutations fell close to or within the ATP binding
cleft (Fig. 1, green) and thus near Tyr19, the target of Swe1
mediated phosphorylation. Other mutations fell in the
PSTAIRE helix involved in cyclin binding and catalytic
function, or the activation loop, a domain involved in
substrate recognition that includes Thr169, the target of
Cak1 phosphorylation (Fig. 1, red). However, nearly one
third of the alleles contained mutations that might
impinge on Cdc28 interaction with Cks1 by altering con-
tact residues, or residues underlying the Cks1 binding sur-
face (Fig. 1, yellow and orange).
We were struck by the high number of mutations poten-
tially affecting Cks1 binding, as this factor had yet to be
directly linked to the apical-isotropic switch or filamen-
Hyper-filamentous, temperature sensitive cdc28 mutants exhibit altered Cks1-binding region Figure 1
Hyper-filamentous, temperature sensitive cdc28 mutants exhibit altered Cks1-binding region. The three-dimen-
sional structure of Cdc28 was modeled from the crystal structure of human CDK2 [3]. Each allele is listed with amino acid sub-
stitutions color coded according to the functional region of the molecule in which it lies: yellow = Cks1 binding, orange = non-
surface residues underlying the Cks1-binding domain, green = ATP-binding, red = cyclin-binding, white = uncharacterized 
structure function relationship, striped = ATP.
Cks1 binding residues
Uncharacterized
Cyclin binding
ATP binding
Cks1 binding domain
V113A, P231L
K151E, F245L, S248G
F90I, R208W
R159C, I284V
Y177H
F245V, D244E, R10I, I218T
C121R, N232I
H292R, F295L
S60P
R35G
S129L, Y177F
Q140K
S213R, S216R, I224T
L228S, L275H
P180L
Y8C, F212L
E89V
T18I, P266S
R43G, Y189H
D75V
V173D
T18I, G33D, L44Q, L152I
N155I, N238G
L150I, G162S
E70G, S197T, N232K
E12G, T54A, I235V
F90I, K115E, L165M
F161S, K274N
E204V
L11P, K40R, K115T, K122E, D265T
L137I, V163A, D270N
Q32R, K151E, S248G
L165S, D265G, H292L
E217V
D215V, R253C
E204K
R43G, W236R
N7K, I284V
N238DCell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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tous differentiation. We examined if normal growth could
be restored in these mutants by high copy CKS1. Indeed,
11 out of 15 alleles exhibited improved growth by CKS1
overexpression (Table 1). Of the 11 mutants suppressed
by  CKS1, four exhibited near wild type restoration of
growth and morphology (1). The point mutants cdc28-
E217V and cdc28-N238D were in this category suggesting
that these alterations were less likely to directly affect
additional partner associations. Although both mutations
lie in the Cks1 binding region, co-crystal studies of the
CDK2-Cks1 interface have demonstrated a direct contact
only for the residue analogous to Cdc28 Glu217 with res-
idues Glu63 and His94 in Cks1 [37]. Importantly, our
bioinformatic analysis using algorithms designed by
Chasman and Adams for assessment of the functional
consequences of amino acid substitutions [38], indicated
that mutation of residue E217 to valine should not other-
wise affect the structure of monomeric Cdc28 (data not
shown). E217 falls in the highly conserved GDSEID
(214–219) motif, previously implicated in Cdc28 binding
to Cks1 [39]. Mutations in residues 212, 213, and 215–
218 were also identified by this screen, indicating that this
domain of Cdc28 is particularly important for regulating
morphological differentiation (Fig. 1).
To better study the genetic interactions of cdc28-E217V,
we performed genomic replacement of endogenous
CDC28 with cdc28-E217V. As expected, transformation of
cdc28-E217V  with high copy CKS1  similarly relieved
mutant phenotypes as previously found in the cdc28-
E217V shuffle strain (Fig. 2A). We also observed decreased
pull-down of Cdc28-E217V compared to wild-type Cdc28
with beads coupled to the S. pombe Cks1 homolog
p13Suc1, under conditions of saturating amounts of Cdc28
and Cdc28-E217V proteins (Fig. 2B). These data strongly
suggest a loss of association of Cdc28 with its essential
partner Cks1 as the basis for the temperature sensitivity in
this mutant. Cdc28-E217V also showed normal Cdc28
protein abundance and levels of Clb2- associated histone
H1 kinase activity at permissive and restrictive tempera-
Table 1: Genetic comparison of temperature sensitive alleles containing mutations in the Cks1 binding domain
Cks1 Binding Domain Mutations Suppression by CKS1 overexpression Suppression by flo8
V113A, P231L + -
K151E, F245L, S248G + -
F245V, D244E, R10I, I218T ++ -
C121R, N232I - -
S213R, S216R, I224T - -
L228S, L275H + -
Y8C, F212L + +
N155I, N238G + +
E70G, S197T, N232K ++ +
E12G, T54A, I235V - +
Q32R, K151E, S248G - -
E217V ++ +
D215V, R253C + +
R43G, W236R + -
N238D ++ +
HIS3-marked plasmids (pRS413) containing temperature sensitive cdc28 alleles were introduced into a CDC28 shuffle strain. Transformants were 
subjected to 5-FOA treatment to evict the wild type copy of CDC28 and assayed for growth at 25°C and 35°C. If growth of a given allele was 
significantly improved by deletion of FLO8 or by overexpression of CKS1, then suppression is indicated by "+". A sign of "-" indicates no change.Cell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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cdc28-E217V cells exhibit specific genetic interactions with cell-cycle regulators Figure 2
cdc28-E217V cells exhibit specific genetic interactions with cell-cycle regulators. A) Growth of cdc28 mutant yeast 
cells containing genomic substitution of E217V transformed with high-copy plasmids harboring CKS1, CAK1, CLN1, CLB2 or no 
insert, or a centromeric plasmid harboring CDC28. B) p13Suc1 beads-pull downs using yeast protein extract prepared from 
wild-type or cdc28-E217V at 30°C. Blots were probed with anti-PSTAIRE CDK antibody. C) Inviability and elongated morphol-
ogy of clb2 cdc28-E217V double mutant segregants.
A
C   cdc28-E217V
         clb2¬ B
                2+—
CEN CDC28
2+CKS1
2+CLN1
2+CAK1
2+CLB2
              2+—
CEN CDC28
2+CKS1
2+CLN1
2+CAK1
2+CLB2
25ºC 30ºC 35ºC
cdc28-E217V 
Wild type 
Suc1-beads 
Pull Down
Extract
Supernatant
WT E217V
WB:  anti-PSTAIRECell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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tures (data not shown), in accordance with previous
reports indicating that Cks1 does not affect mitotic CDK
kinase activity [32].
However, we further questioned if the defects of this
mutant were specifically attributable to its diminished
interaction with Cks1. As a means to examine this possi-
bility we tested overexpression of the CDK-activating
kinase CAK1 in cdc28-E217V cells. Cak1 is an essential
CDK activator that phosphorylates Cdc28 on Thr169 in
the T loop to promote kinase activity, substrate accessibil-
ity and cyclin binding [40,41]. If Cak1 overexpression
were to alleviate cdc28-E217V defects, it could indicate
that cdc28-E217V harbors intrinsic defects in CDK func-
tion or in interaction with other binding partners or sub-
strates. However, high copy CAK1 neither suppressed nor
enhanced cdc28-E217V defects (Fig. 2A). Dephosphoryla-
tion of Thr169 has been shown to be likely mediated by
phosphatases Ptc2 and Ptc3 [42]. We found that overex-
pression of PTC2 and PTC3 was similarly toxic to wild-
type and cdc28-E217V cells (data not shown). Thus, cdc28-
E217V phenotypes are not affected by alteration of activat-
ing phosphorylation of Cdc28. This further substantiates
that cdc28-E217V defects are specific to interaction with
Cks1.
Given the well-established roles of Cln1 and Clb2 cyclins
at the G1/S and the G2/M transitions respectively, as well
as their opposing effects on the apical-isotropic switch, we
examined modulation of cdc28-E217V  phenotypes by
CLB2  and  CLN1.  CLB2  overexpression partly restored
cdc28-E217V growth at semi-permissive temperature (Fig.
2A) while cdc28-E217V clb2 double mutant segregants
were inviable, germinating to form only elongated, termi-
nal buds (Fig. 2C). In turn, CLN1 overexpression dimin-
ished proliferation at semi-permissive temperature (Fig.
2A) while deletion of CLN1 partly restored growth (data
not shown). These results further support that the pheno-
type of cdc28-E217V is due to delayed mitotic progression.
Protein Kinase A pathway impinges on Cdc28
In filamentous growth signaling, Ras2 activates both the
PKA pathway and the Kss1-MAPK cascade [43]. We ques-
tioned if cdc28-E217V  phenotypes were dependent on
Ras2 signaling. Deletion of RAS2 restored near wild-type
growth and morphology to cdc28-E217V cells (Fig. 3A,B).
Two transcriptional regulators, Flo8 and Sfl1, function as
downstream effectors of the PKA pathway [13]. Deletion
of FLO8 partially alleviated both the growth and mor-
phology defects of cdc28-E217V (Fig. 3C,D), whereas dele-
tion of SFL1 showed no effect (Fig. 4A). Deletion of TEC1,
a transcription factor required for MAPK signaling, also
did not alter cdc28-E217V growth or morphology (Fig. 4B,
C). These results suggested that the Ras2-activated PKA
pathway specifically impinged on cdc28-E217V through
Flo8. Providing further confirmation of this connection
we found that a high-copy plasmid harboring the cAMP
phosphodiesterase  PDE2, a negative regulator of PKA,
suppressed  cdc28-E217V  defects (data not shown)
[44,45].
It has also been reported that the PKA pathway, but not
the Kss1-MAPK cascade, may be required for activation of
filamentation during amino acid starvation by the tran-
scription factor Gcn4 [46]. In accordance, we observed
that deletion of GCN4  provided some suppression to
cdc28-E217V cells (Fig. 3E). As a final test we reexamined
each of the Cks1-binding mutants for genetic interaction
with FLO8. Interestingly less that half of these mutants
were suppressed by deletion of FLO8  (Table 1). These
observations indicate that the interaction of PKA through
Flo8 with Cdc28 may be highly specific to a particular
mechanism of CDK regulation.
Swe1 is modulated by PKA and Cks1
These results supported the Ras2-activated PKA pathway
via Flo8 to be an important regulator of Cdc28. Previous
genetic evidence by La Valle and Wittenberg suggested
that Swe1 regulation of Cdc28 may be an effector of PKA
[18]. Therefore, we directly tested if Swe1 function is mod-
ulated by the PKA pathway. We found that deletions of
RAS2, FLO8, or the filamentous-growth specific PKA cata-
lytic subunit TPK2 [47] in otherwise wild-type cells each
diminished Cdc28 Tyr19 phosphorylation, placing the
PKA signaling upstream of Swe1 and Cdc28 (Figure 5A).
Given the relationship between PKA and Swe1, we also
tested if cdc28-E217V is modulated by SWE1. Strikingly,
deletion of SWE1 conferred suppression of both growth
and morphology defects of cdc28-E217V  (Fig. 5B, C).
Again, we asked if these effects were specific to Swe1 or if
the absence of any negative regulator of CDK function
would improve cdc28-E217V defects. Toward examining
this question, we observed that deletion of the Cdc28 sto-
ichiometic inhibitor SIC1  had only subtle effects on
growth of cdc28-E217V cells [48].
One interpretation of these data is that Swe1 functions
upstream of Cks1. Nonetheless, arguing against a role for
Swe1 binding or Cdc28 Tyr19 phosphorylation in modu-
lating Cks1 binding, Cdc28 was pulled down by p13suc1
beads to a similar extent from extracts of cells lacking
SWE1 or its opposing phosphatase, MIH1 (Fig. 6A). An
alternative explanation is that Cks1 antagonizes Cdc28
binding to or phosphorylation by Swe1. However, GST-
Swe1 beads pulled down Cdc28-E217V and wild-type
Cdc28 with similar levels, and independent of expression
of high copy CKS1. In turn, increased Cdc28 Tyr19 phos-
phorylation was not detected in the mutant cells (data notCell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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Ras2-mediated PKA pathway impinges on Cdc28 Figure 3
Ras2-mediated PKA pathway impinges on Cdc28. A) Growth and B) Morphology of cdc28-E217V ras2, wild-type, 
cdc28-E217V, or ras2 cells growing at 25, 30 or 35°C. C) Growth and D) morphology of cdc28-E217V flo8 double mutants 
compared to wild-type, cdc28-E217V and flo8 cells at 25, 30 or 35°C. E) Growth of cdc28-E217V gcn4 double mutants com-
pared to wild-type, cdc28-E217V and gcn4 cells at 30°C and 35°C.
WT
cdc28-E217V
flo8 
cdc28-E217V
              flo8 
25˚C 35˚C 30˚C
B
WT
cdc28-E217V
flo8$
cdc28-E217V flo8$
25ºC 30ºC 35ºC
WT
cdc28-E217V
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D
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cdc28-E217V is not affected by deletion of TEC1 or SFL1 Figure 4
cdc28-E217V is not affected by deletion of TEC1 or SFL1. A) Growth of wild type, sfl1, cdc28-E217V strains and sfl1 
cdc28-E217V double mutants was examined using of 5-fold serial dilutions of saturated cultures at 30°C and 35°C B) Growth 
of cdc28-E217V tec1 double mutants compared to wild-type, cdc28-E217V and tec1 cells at 25 and 35°C. C) Effect of deletion of 
TEC1 on morphology of cdc28-E217V at 25, 30 or 35°C.
B
C
WT
cdc28-E217V
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30ºC 35ºCCell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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PKA controls Swe1 regulation of Cdc28 Figure 5
PKA controls Swe1 regulation of Cdc28. A) Western blot analysis of Cdc28 Tyr19 phosphorylation in swe1, mih1, ras2, 
tpk2, flo8, or wild-type cells grown to log phase at 30°C. B) Growth of cdc28-E217V swe1 double mutants compared to wild-
type, cdc28-E217V and swe1 cells at 25, 30 or 35°C. C) Morphology of cdc28-E217V swe1 double mutants at 25, 30 or 35°C 
compared to wild-type, cdc28-E217V and swe1 cells.
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flo8 
anti-phospho-
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shown). Together, these results argue against Swe1 and
Cks1 binding competitively to Cdc28.
An alternative link to Cks1 is that Swe1 protein might
accumulate and/or persist abnormally in cdc28-E217V
cells. Western blot analysis of the cdc28-E217V  cells
revealed accumulation of Myc epitope-tagged Swe1,
which appeared as a range of apparent molecular weights,
a pattern previously ascribed to Swe1 phosphorylation
[49] (Fig. 6B). To further pursue a role for Cks1 in Swe1
function, we examined cells lacking CDC55, a protein
phosphatase 2A (PP2A) regulatory subunit that promotes
Swe1 degradation. cdc55 mutants contain elevated levels
of Swe1 and show morphological defects including slow
growth, elongated morphology and increased Cdc28
Tyr19 hyperphosphorylation at 16°C, which are relieved
by deletion of SWE1 [50]. Strikingly, high copy CKS1 also
strongly suppressed the growth and morphology defects
Increased Swe1 protein levels mediate cdc28-E217V defects Figure 6
Increased Swe1 protein levels mediate cdc28-E217V defects. A) p13Suc1 beads pull-downs of Tyr19-phosphorylated and 
unphosphorylated Cdc28 from protein extracts prepared from swe1 or mih1 deletion strains. B) Western blot analysis of Myc-
tagged Swe1 protein levels from wild-type and cdc28-E217V cells grown to log phase at 25°C and shifted to 37°C, or kept at 
25°C for 4 h.
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of cdc55 mutants and reduced Cdc28 Tyr19 phosphoryla-
tion (Fig. 7A, B, C). These results suggest that Cks1
opposes Swe1 accumulation and inhibitory phosphoryla-
tion.
Discussion
Ras2-mediated signaling has been well studied in filamen-
tous growth. Despite this, the extent of crosstalk between
the Ras2-MAPK and Ras2-PKA pathways is uncertain.
Although traditionally thought of as parallel pathways
[8], there has been some evidence that the Kss1 MAPK
pathway may inhibit the PKA pathway [51] and that Flo8
and Tec1 participate in shared complexes at promoters
[52]. Our results indicate that cdc28-E217V cells are mod-
ulated by the PKA pathway, most likely via FLO8 though
the direct targets that mediate this interaction are yet to be
established. Deletions of a second downstream compo-
nent of PKA signaling, SFL1, or the Ras2-MAPK transcrip-
tional effector TEC1 did not show any genetic interaction
with cdc28-E217V. La Valle and Wittenberg have shown
that deletion of SWE1 restores filamentous growth to flo8
PKA signaling mutants [18]. Our results extend these find-
ings to suggest the PKA pathway regulates filamentous
growth in part by activating Swe1 to phosphorylate Cdc28
Tyr19. Given that cdc28-E217V  phenotypes partially
depend upon the PKA pathway including FLO8, but not
the MAPK cascade, we suggest that the regulation of
Cdc28 by Swe1 and Cks1 is likely specifically mediated by
PKA.
A paradigm for signaling cascades that culminate in acti-
vation of a CDK regulator has been previously observed in
the response of haploid yeast to mating pheromone that
galvanizes the Ste-MAPK cascade leading to activation of
the MAPK Fus3 [53]. Fus3 positively regulates the CDK
inhibitor Far1 directly by phosphorylation and indirectly
by transcriptional regulation. In turn, Far1 negatively reg-
ulates Cln-associated Cdc28 complexes by inhibiting
kinase activity and altering its localization [54-56]. Inter-
estingly, Far1 is also subject to a negative feedback loop
involving phosphorylation by Cln-associated Cdc28 that
is thought to lead to ubiquitination and degradation of
Far1 [57]. We have shown that PKA-signaling pathway via
Flo8 regulates Swe1-mediated Cdc28 Tyr19 phosphoryla-
tion, and that SWE1 mediates cdc28-E217V phenotypes.
Similarly to Far1, Swe1 is a known Cdc28 substrate [6,22].
Swe1 has been found to make direct contact with the
hydrophobic patch of Clb2 initially stabilizing cyclin-
Cdc28 complexes prior to its hyperphosphorylation [58],
providing a mechanism for feedback inhibition analo-
gous to that of Far1.
cdc28-E217 cells exhibit increased levels of Swe1 protein.
Complex post-translational modification of Swe1 leads to
several different mobility species [49]. Interestingly, each
form accumulates in cdc28-E217V cells, suggesting that
cdc28-E217V cells are competent to mediate phosphoryla-
tion and ubiquitination of Swe1. This is supported by the
observation that Cdc28-E217V exhibits normal kinase
activity toward histone H1 and exhibits physical associa-
tion with Swe1 comparable to wild type Cdc28.
Many CDK substrates are subject to subsequent ubiquiti-
nation and proteasome-dependent degradation including
cyclins, the stoichiometric inhibitor Sic1, and the securin
Pds1 [59,60]. Ubiquitination of proteins is mediated by
two complexes, the Skp1-cullin-F-box-protein complex
(SCF) and the Anaphase-Promoting Complex (APC).
Although SCF complex functions at multiple cell cycle
transitions, the APC is thought to function only during
mitosis. Substrate specificity of each of these complexes is
determined in part by F-box subunits for the SCF, and
WD-repeat containing proteins for the APC [26,61]. That
the Cdc28-Cks1 physical interaction may be important in
the downregulation of Swe1, a CDK substrate, suggests
that one role of Cks1 may be to recruit the protein degra-
dation machinery to CDK complexes. Such a role has been
reported for the mammalian Cks1, which facilitates ubiq-
uitination and degradation of p27, a CDK stoichiometric
inhibitor [62].
In yeast, Cks1 and Cdc28 have been reported to interact
with the 26S proteasome [30]. Morris and Reed have pro-
posed a model in which Cks1 recruitment of the proteas-
ome and Cdc28 is important for displacement of CDK
from specific promoters in a novel mechanism of tran-
scriptional regulation [29,63]. Crystal studies of mamma-
lian Cks1 have suggested that Cks1 exists as both a
monomer and a multimer, although the regulation and
function of this transition is not known [64]. Bourne and
Tainer have suggested that Cks1 dimerization forms a
pocket which may serve to shuttle phospho-proteins [64].
Further recent evidence has shown that Cks1 interacts
directly with monoubiquitin and tetraubiquitin [65].
Together, these findings suggest that Cks1 may facilitate
transition of ubiquitinated CDK substrates to the proteas-
ome.
Understanding of events leading to Swe1 degradation
however has proven elusive. Kaiser and Reed have shown
that the SCF subunit Met30 interacts physically with Swe1
and that met30 mutants exhibit stabilization of Swe1 pro-
tein expressed from an inducible promoter [66]. It is also
suggested that in vitro translated Swe1 exhibits lower
mobility forms on exposure to whole yeast extract that are
dependent on the presence of Met30 [66]. However, stud-
ies from the Lew laboratory have shown that deletion of
MET30, unlike HSL7, does not enhance the filamentous
phenotype caused by deletion of the opposing Tyr19
phosphatase MIH1 [22]. Further, they have also shownCell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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Cks1 opposes Swe1 function in cdc55 mutants Figure 7
Cks1 opposes Swe1 function in cdc55 mutants. A) Growth and B) Morphology of cdc55 mutants (W303 background) at 
16 and 37°C transformed with high copy CKS1 or empty vector. C) Cdc28 Tyr19 phosphorylation in cdc55 deletion mutants 
(W303 background) transformed with high copy CKS1 or empty vector.
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that double deletion of MET30 and another SCF subunit
MET4 does not stabilize Swe1 protein levels. To further
examine Swe1 regulation, McMillan and colleagues meas-
ured Cdc28 tyrosine phosphorylation in the absence of
each of 13 deletions of non-essential F-box subunits, none
of which showed an appreciable increase [22]. Finally,
Kellogg has suggested that Swe1 protein is present
throughout mitosis and that degradation may not be a
primary mechanism of regulation [49,67]. Our findings
support that Swe1 protein levels are subject to regulation
that depends on Cks1.
That Cks1 may have a role in regulating protein stability
may also explain the genetic interaction of cdc28-E217V
with the PKA pathway. Bolte and Irniger have found that
RAS2-V19 enhances the growth defects of mutants of the
APC through a mechanism that depends on activation of
adenylate cyclase [24]. Conversely, deletion of RAS2 or
overexpression of PDE2 diminishes the growth defects of
APC mutants. However, it has also been observed that
deletion of RAS2 may have the opposite effect on SCF
mutants, actually enhancing growth defects [25].
Conclusion
Our results indicate that the RAS-mediated PKA pathway
and Cks1 are important regulators of Swe1 and, thereby,
of Cdc28-Clb2 mitotic function during yeast filamentous
growth. The phenotypes of cdc28-E217V, a mutant defi-
cient for proper Cdc28-Cks1 association, are partly
dependent on the presence of PKA pathway components
and Swe1. Swe1 accumulates in the cdc28-E217V  cells
supporting prior studies showing that association of Swe1
with Clb2 mediates negative feedback provided by CDK
phosphorylation [62]. Overexpression of CKS1 restores
near wild-type growth, morphology and Cdc28 Tyr19
phosphorylation to cdc55 mutant cells defective for Swe1
degradation. Future studies elucidating the precise degra-
dation machinery required for Swe1 turnover will be
important in understanding the importance of the PKA
pathway in regulating Cdc28 CDK activity.
Methods
Strain construction
Gene replacement, allele integration, yeast mating, and
yeast transformation were as described [3,68]. For genetic
analyses, multiple tetratypes were examined. Yeast strains
were constructed in the Sigma 1278b background unless
indicated. Strains and plasmids were derived from the fol-
lowing:
Strains
SKY750 – MATa/α cdc28::TRP1/cdc28::TRP1 his3 [pCT3
CDC28 URA3]; SKY768 – MATa clb1::TRP1 ura3; SKY772
– MATa clb2::LEU2 ura3; SKY901 – MATα swe1::LEU2
ura3; SKY903 – MATα mih1::LEU2 ura3; SKY985 – MATa
cln1::URA3 cln2::LEU2 trp1; SKY2244 – MATα ura3 his3
leu2 trp1; SKY2256 – MATa/MATα ura3/ura3 his3/his3
leu2/LEU2 trp1/TRP1; SKY2264 – MATa ura3 his3;
SKY2618 – MATa ras2::kanMX6 ura3 his3 leu2; SKY3003
– MATa/MATα cdc28-E217V:kanMX6/cdc28-
E217V:kanMX6; SKY3004 – MATa/MATα CDC28/cdc28-
E217V:kanMX6; SKY3005 – MATα cdc28-E217V:kanMX6
ura3 his3 leu2; SKY3006 – MATα SWE1-13Myc:kanMX6;
SKY3007 – MATa flo8::kanMX6 ura3 his3 trp1; SKY3008
– MATα sfl1::kanMX6 his3; SKY3009 – MATα
tec1:kanMX6 ura3 his3; SKY3010 – MATa tpk2::kanMX6
ura3 his3 leu2 trp1; SKY3011 – MATa cdc55::kanMX6
ura3 his3 trp1 (W303); SKY3012 – MATa gcn4::HIS3 ura3
leu2
Plasmids
pSKB4250 – YEplac195 2 μ URA3 GAL> (gift of M. Solo-
mon); pSKB4251 – YEplac195 2 μ URA3 GAL>PTC2 (gift
of M. Solomon); pSKB4252 – YEplac195 2  μ URA3
GAL>PTC3 (gift of M. Solomon); pSKB4253 – pRS202 2 μ
URA3 CLB2; pSKB4254 – pRS 202 2 μ  URA3 CAK1;
pSKB4255 – pRS202 2 μ  URA3 CLN1; pSKB4256 –
pRS202 2 μ URA3 CKS1; pSKB4257 – pRS202 2 μ URA3;
pSKB4258 – pCT3 CEN URA3 CDC28; pSKB4259 –
pGEX-3x-GST-SWE1 [69] (gift of J. Thorner); pSKB4260 –
pGEX-3x-GST (gift of J. Thorner); pRS413-cdc28 library
CEN HIS3
Screen for cdc28 mutants
A degenerate-PCR derived library of cdc28 mutants cloned
into pRS413 was used to transform SKY750 [3]. The trans-
formants were then replica-plated onto 5-Fluoroorotic
acid (5-FOA)-containing media to evict the CEN URA3
CDC28  plasmid. About 50,000 5-FOAR  colonies were
plated on synthetic low ammonia dextrose (SLAD) media.
Five hundred colonies exhibiting enhanced filamentous
growth were isolated and from these, 64 showed dramat-
ically reduced growth at 35°C. Plasmids were rescued and
re-introduced in SKY750. After 5-FOA treatment, 39 were
found to confer a strong phenotype and were sequenced.
Genomic integration of the E217V mutation into
SKY2256 was as described [68]. Tetrad analysis and DNA
sequencing were used to confirm the integration.
Bioinformatic Analysis
The effect of polymorphism at E217 was studied as
described [38]. Molecular modeling was performed as
described [3] using Swiss-Model and Swiss-PDB-Viewer
[70,71].
Spot Tests
Yeast cultures were grown to saturation in rich or selective
liquid media at 22°C. Saturated cultures were diluted seri-
ally at a ratio of 1/5 and spotted onto rich or selective agar
medium. We have found the cdc28 mutants, possibly inCell Division 2009, 4:12 http://www.celldiv.com/content/4/1/12
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part of because of the essential nature of many Cdc28
functions, have a tendency to acquire genomic and intra-
genic suppressor mutations. Because of this, we repeated
spot testing at least four times for each experiment and a
representative assay is shown. Each of the experimental
groups shown within a given experiment were performed
together on the same plate at each temperature. Images
were acquired with a Pixera Professional camera on a Zeiss
inverted microscope using brightfield illumination and
contrast-enhanced in Adobe Photoshop. Magnification
for detail of growth and morphology was performed in
accord with previously published assessments of filamen-
tation [72,73].
Biochemical Analyses
Yeast extracts were prepared from log phase cultures by
bead beating in buffer containing 50 mM Tris pH 7.6,
10% glycerol, 0.5% NP-40, 2 mM EDTA, 250 mM NaCl, 1
mM phenylmethylsulphonyl fluoride, and protease
inhibitor cocktail (Roche). Protein content was deter-
mined by Bradford assay. For Western blot analysis, pro-
teins separated by SDS-PAGE were transferred to
nitrocellulose membranes, and blocked in TBS-Tween-20
containing 5% milk, or 5% BSA for anti-phospho-Tyr15
Cdc2 antibody (Cell Signaling Technologies). Membranes
were probed with polyclonal anti-Myc (A14, Santa Cruz)
at 1/1000 dilution, anti-PSTAIRE (Santa Cruz) at 1/500,
anti-phospho-Tyr15 Cdc2 (Cell Signaling Technologies)
at 1/1000, or anti-PGK (Molecular Probes) at 1/2500.
Membranes were washed 3× with TBS-Tween-20 and
probed with HRP-linked anti-rabbit or anti-mouse IgG
(Amersham) at 1/2500. For p13Suc1 pull-down reactions,
1 mg of protein extract was incubated overnight at 4°C
with 50 μ l of p13Suc1 Sepharose bead slurry (Upstate).
Beads were washed five times with extract buffer, boiled in
sample buffer and the supernatants subjected to SDS-
PAGE. For binding assays using GST-Swe1 coated glutath-
ione beads, 1 mg of yeast extract was incubated overnight
with 100 μ l of 50% glutathione bead slurry and treated as
for p13Suc1 Sepharose beads. GST-Swe1 was isolated from
E. coli BL21(DE3) plysS harboring pGEX-GST-SWE1 [69],
a kind gift from Jeremy Thorner. Bacteria were grown to
an O.D.600 of 0.6, induced for 3 h at 37°C with 0.2 mM
IPTG, and briefly sonicated in PBS buffer containing pro-
tease inhibitor cocktail, 1 mM PMSF, 1 mM Orthovanad-
ate, 0.5 mM DTT, and 1% Triton X-100. Glutathione
beads were incubated with 1–2 mg of protein extract over-
night at 4°C. GST-Swe1 coated beads were washed five
times with PBS and incubated with extracts.
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